Effects of vasopressin V1-receptor blockade during acute and sustained hypovolemic hypotension

American Journal of Physiology - Regulatory Integrative and Comparative Physiology

Volumn 270, Issue 2 39-2, 1996, Pages

  Wall, Barry M ^a   Hugh, Kim M ^b   Runyan, Keith R ^b   Williams, Hugh H ^b   Gavras, Haralambos ^b   Cooke, C Robert ^b  

^a VETERANS AFFAIRS MEDICAL CENTER   (United States)

^b NONE

Author keywords

arginine vasopressin receptor antagonists; blood pressure; spinal cord injury

Indexed keywords

ALDOSTERONE; HYDROCORTISONE; RENIN; VASOPRESSIN; VASOPRESSIN V1 RECEPTOR; ARGIPRESSIN; VASOPRESSIN RECEPTOR;

ADULT; AGED; ALDOSTERONE BLOOD LEVEL; ARTICLE; CERVICAL SPINAL CORD INJURY; CLINICAL ARTICLE; HEAD TILTING; HORMONE RESPONSE; HUMAN; HYDROCORTISONE BLOOD LEVEL; HYPOTENSION; HYPOVOLEMIA; MALE; PLASMA RENIN ACTIVITY; PRIORITY JOURNAL; RECEPTOR BLOCKING; VASOPRESSIN BLOOD LEVEL; BLOOD; BLOOD PRESSURE; BLOOD VOLUME; BODY POSTURE; DRUG ANTAGONISM; METABOLISM; MIDDLE AGED; PATHOPHYSIOLOGY; SPINAL CORD INJURY; TIME;

ADULT; AGED; ARGININE VASOPRESSIN; BLOOD PRESSURE; BLOOD VOLUME; HEAD-DOWN TILT; HUMANS; HYPOTENSION; MALE; MIDDLE AGED; RECEPTORS, VASOPRESSIN; RENIN; SPINAL CORD INJURIES; TIME FACTORS;

EID: 0030078088     PISSN: 03636119     EISSN: None     Source Type: Journal    
DOI: 10.1152/ajpregu.1996.270.2.r356     Document Type: Article

References (42)

1. Andrews, C. E., Jr., and B. M. Brenner. Relative contributions of arginine vasopressin and angiotensin II to maintenance of systemic arterial pressure in the anesthetized water-deprived rat. Circ. Res. 48: 254-258, 1981.
2. Armitage, P., and G. Berry. Statistical Methods in Medical Research (2nd ed). Oxford, UK: Blackwell, 1987, p. 273-282.
3. Aylward, P. E., J. S. Floras, W. N. Leimbach, Jr., and F. M. Abboud. Effects of vasopressin on the circulation and its baroreflex control in healthy men. Circulation 73: 1145-1154, 1986.
4. Bichet, D. G., M. Razi, M. F. Arthus, M. Lonergan, P. Tittley, R. K. Smiley, G. Rock, and D. J. Hirsch. Epinephrine and dDavp administration in patients with congenital nephrogenic diabetes insipidus. Kidney Int. 36: 859-866, 1989.
5. Bichet, D. G., M. Razi, M. Lonergan, M. F. Arthus, V. Papukna, C. Kortas, and J. N. Barjon. Hernodynamic and coagulation responses to 1-desamino[8-D-arginine] vasopressin in patients with congenital nephrogenic diabetes insipidus. N. Engl. J. Med. 318: 881-887, 1988.
6. Bie, P., N. H. Secher, A. Astrup, and J. Warberg. Cardiovascular and endocrine responses to head-up tilt and vasopressin infusion in humans. Am. J. Physiol. 251 (Regulatory Integrative Comp. Physiol. 20): R735-R741, 1986.
7. Brand, P. H., P. J. Metting, and S. L. Britton. Support of arterial blood pressure by major pressor systems in conscious dogs. Am. J. Physiol. 255 (Heart Circ. Physiol. 24): H483-H491, 1988.
8. Corbett, J. L., H. L. Frankel, and P. J. Harris. Cardiovascular responses to tilting in tetraplegic man. J. Physiol. Lond. 215: 411-431, 1971.
9. Cowley, A. W., Jr., S. J. Switzer, and M. M. Guinn. Evidence and quantification of the vasopressin arterial pressure control system in the dog. Circ. Res. 46: 58-67, 1980.
10. Crofton, J. T., H. Dustan, L. Share, and D. P. Brooks. Vasopressin secretion in normal black and white men and women on normal and low sodium diets. J. Endocrinol. 108: 191-199, 1986.
11. Crofton, J. T., and L. Share. Sexual dimorphism in vasopressin and cardiovascular response to hemorrhage in the rat. Circ. Res. 66: 1345-1353, 1990.
12. Davies, R., J. D. H. Slater, M. L. Forsling, and N. Payne. The response of arginine vasopressin and plasma renin to postural change in normal man, with observations on syncope. Clin. Sci. Mol. Med. 51: 267-274, 1976.
13. Figoni, S. F. Cardiovascular and haemodynamic responses to tilting and to standing in tetraplegic patients: a review. Paraplegia 22: 99-109, 1984.
14. Gavras, H., A. B. Ribeiro, O. Kohlmann, M. Saragoca, R. A. Mulinari, O. Ramos, and I. Gavras. Effects of a specific inhibitor of the vascular action of vasopressin in humans. Hypertension Dallas 6, Suppl I. I-156-I-160, 1984.
15. Glantz, S. A., and B. K. Slinker. Primer of Applied Regression and Analysis of Variance. New York: McGraw-Hill. 1990, p. 381-390.
16. Gregory, L. C., E. W. Quillen, Jr., L. C. Keil, D. Chang, and I. A. Reid. Effect of vasopressin blockade on blood pressure during water deprivation in intact and baroreceptor-denervated conscious dogs. Am. J. Physiol. 254 (Endocrinol. Metab. 17): E490-E495, 1988.
17. Hirsch, A. T., V. J. Dzau, J. A. Majzoub, and M. A. Creager. Vasopressm-mediated forearm vasodilation in normal humans. J Clin. Invest. 84: 418-426, 1989.
18. Hirsch, A. T., J. A. Majzoub, C. J. Ren, K. M. Scales, and M. A. Creager. Contribution of vasopressin to blood pressure regulation during hypovolemic hypotension in humans. J. Appl. Physiol. 75: 1984-1988, 1993.
19. Hock, C. E., J. Y. Su, and A. M. Lefer. Role of AVP in maintenance of circulatory homeostasis during hemorrhagic shock. Am. J. Physiol. 246 (Heart Circ. Physiol. 15): H174-H179, 1984.
20. Houck, P. C., M. J. Fiksen-Olsen, S. L. Britton, and J. C. Romero. Role of angiotensin and vasopressin on blood pressure of ganglionic blocked dogs. Am. J. Physiol. 244 (Heart Circ. Physiol. 13): H115-H120, 1983.
21. 1-receptor antagonism in barorcflex-deficient subjects. Am. J. Physiol 268 (Regulatory Integrative Comp. Physiol. 37): R156-R163, 1995.
22. Liard, J. F. Cardiovascular effects associated with antidiuretic activity of vasopressin after blockade of its vasoconstrictor action in dehydrated dogs. Circ. Res. 58: 631-640, 1986.
23. 2 vasopressin blockade after hemorrhage in conscious dogs. Am. J. Physiol. 255 (Heart Circ. Physiol. 24): H1325-H1329, 1988.
24. Mathias, C. J., N. J. Christensen, J. L. Corbett, H. L. Frankel, T. J. Goodwin, and W. S. Peart. Plasma catecholamincs, plasma renin activity and plasma aldosterone in tetraplegic man, horizontal and tilted. Clin. Sci. Mol. Med. 49: 291-299, 1975.
25. Moses, A. M., C. Jones, and C. B. Yucha. Effects of sodium intake, furosemide, and infusion of atrial natriuretic peptide on the urinary and metabolic clearance of arginine vasopressin in normal subjects. J. Clin. Endocrinol. Metab. 70: 222-229, 1990.
26. 2 receptors in conscious dogs. Am. J. Physiol. 265 (Regulatory Integrative Comp. Physiol. 34): R934-R942, 1993.
27. Ozean, O., I. H. Ulus, M. Yurtkuran, and M. Karakaya. Release of vasopressin, Cortisol and β-endorphin in tetraplegic subjects in response to head-up tilt. Paraplegia 29: 120-124, 1991.
28. Poole, C. J. M., T. D. M. Williams, S. L. Lightman, and H. L. Frankel. Neuroendocrine control of vasopressin secretion and its effect on blood pressure in subjects with spinal cord transection. Brain 110: 727-735, 1987.
29. Ribeiro, A., R. Mulinari, I. Gavras, O. Kohlmann, O. Rainos, and H. Gavras. Sequential elimination of pressor mechanisms in severe hypertension in humans. Hypertension Dallas 8, Suppl I: I-169-I-173, 1986.
30. Ryan, K. L., R. M. Thornton, and D. W. Proppe. Vasopressin contributes to maintenance of arterial blood pressure in dehydrated baboons. Am. J. Physiol. 256 (Heart Circ. Physiol. 25): H486-H492, 1989.
31. Saad, C. I., A. B. Ribeiro, M. T. Zanella, R. A. Mulinari, I. Gavras, and H. Gavras. The role of vasopressin in blood pressure maintenance in diabetic orthostatic hypotension. Hypertension Dallas 11, Suppl 1: I-217-I-221, 1988
32. Schadt, J. C., and E. M. Hasser. Interaction of vasopressin and opioids during rapid hemorrhage in conscious rabbits. Am. J. Physiol. 260 (Regulatory Integrating Comp. Physiol. 29): R373-R381, 1991.
33. Schwartz, J., L. C. Keil, J. Maselli, and I. A. Reid. Role of vasopressin in blood pressure regulation during adrenal insufficiency. Endocrinology 112: 234-238, 1983.
34. Schwartz, J., and I. A. Reid. Effect of vasopressin blockade on blood pressure regulation during hemorrhage in conscious dogs. Endocrinology 109: 1778-1780, 1981.
35. Schwartz, J., and I. A. Reid. Role of vasopressin in blood pressure regulation in conscious water-deprived dogs. Am J. Physiol. 244 (Regulatory Integrative Comp. Physiol. 13): R74-R77, 1983.
36. Tagawa, T., T. Imaizumi, T. Endo, M. Shiramoto.Y. Hirooka, S. Ando, and A. Takeshita. Vasodilatory effect of arginine vasopressin is mediated by nitric oxide in human forearm vessels. J. Clin. Invest. 92: 1483-1490, 1993.
37. Wall, B. M., K. R. Runyan, H. H. Williams, M. A. Bobal, J. T. Crofton, L. Share, and C. R. Cooke. Characteristics of vasopressin release during controlled reduction in arterial pressure. J. Lab. Clin. Med. 124: 554-563, 1994.
38. Wall, B. M., H. H. Williams, D. N. Presley, J. T. Crofton, E. G. Schneider, L. Share, and C. R. Cooke. Altered sensitivity of osmotically stimulated vasopressin release in quadriplegic subjects. Am. J. Physiol. 258 (Regulatory Integrative Comp. Physiol. 27): R827-R835, 1990.
39. Walker, B. R. Evidence for a vasodilatory effect of vasopressin in the conscious rat. Am. J. Physiol. 251 (Heart Circ. Physiol. 20) H34-H39, 1986.
40. Williams, T. D. M., S. L. Lightman, and M. J. Leadbeater. Hormonal and cardiovascular responses to DDAVP in man. Clin Endocrinol. 24: 89-96, 1986.
41. Woods, R. L., and C. I. Johnston. Contribution of vasopressin to the maintenance of blood pressure during dehydration. Am. J Physiol. 245 (Renal Fluid Electrolyte Physiol. 14): F615-F621. 1983.
42. Zerbe, R. L., M. A. Bayorh, and G. Feuerstein. Vasopressin an essential presser factor for blood pressure recovery following hemorrhage. Peptides 3: 509-514, 1982.